Catalyst Biosciences Probability of Future Stock Price Finishing Over 0.41
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Catalyst |
Catalyst Biosciences Target Price Odds to finish over 0.41
The tendency of Catalyst Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.41 | 90 days | 0.41 | about 1.98 |
Based on a normal probability distribution, the odds of Catalyst Biosciences to move above the current price in 90 days from now is about 1.98 (This Catalyst Biosciences probability density function shows the probability of Catalyst Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Catalyst Biosciences has a beta of -1.16 suggesting as returns on its benchmark rise, returns on holding Catalyst Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Catalyst Biosciences is expected to outperform its benchmark. Moreover Catalyst Biosciences has an alpha of 1.1035, implying that it can generate a 1.1 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Catalyst Biosciences Price Density |
| Price |
Predictive Modules for Catalyst Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Catalyst Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Catalyst Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Catalyst Biosciences is not an exception. The market had few large corrections towards the Catalyst Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Catalyst Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Catalyst Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.10 | |
β | Beta against Dow Jones | -1.16 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.15 |
Catalyst Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Catalyst Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Catalyst Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Catalyst Biosciences is not yet fully synchronised with the market data | |
| Catalyst Biosciences has some characteristics of a very speculative penny stock | |
| Catalyst Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 794 K. Net Loss for the year was (8.24 M) with loss before overhead, payroll, taxes, and interest of (64.91 M). | |
| Catalyst Biosciences currently holds about 75.39 M in cash with (33.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company shares are held by company insiders |
Catalyst Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Catalyst Stock often depends not only on the future outlook of the current and potential Catalyst Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catalyst Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.5 M | |
| Cash And Short Term Investments | 21.7 M |
Catalyst Biosciences Technical Analysis
Catalyst Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Catalyst Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Catalyst Biosciences. In general, you should focus on analyzing Catalyst Stock price patterns and their correlations with different microeconomic environments and drivers.
Catalyst Biosciences Predictive Forecast Models
Catalyst Biosciences' time-series forecasting models is one of many Catalyst Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Catalyst Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Catalyst Biosciences
Checking the ongoing alerts about Catalyst Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Catalyst Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Catalyst Biosciences is not yet fully synchronised with the market data | |
| Catalyst Biosciences has some characteristics of a very speculative penny stock | |
| Catalyst Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 794 K. Net Loss for the year was (8.24 M) with loss before overhead, payroll, taxes, and interest of (64.91 M). | |
| Catalyst Biosciences currently holds about 75.39 M in cash with (33.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |